A phase I trial of PTK787/ZK222584 [vatalanib] in combination with bevacizumab (Avastin) in patients with refractory and/or advanced malignancies.
Phase of Trial: Phase I
Latest Information Update: 24 Nov 2013
At a glance
- Drugs Bevacizumab; Vatalanib
- Indications Solid tumours
- Focus Adverse reactions
- 22 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Mar 2008 New trial record.